Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

Bioenergetic gain of citrate anticoagulated continuous hemodiafiltration--a comparison between 2 citrate modalities and unfractionated heparin.

Balik M, Zakharchenko M, Leden P, Otahal M, Hruby J, Polak F, Rusinova K, Stach Z, Tokarik M, Vavrova J, Jabor A, Oudemans-van Straaten HM.

J Crit Care. 2013 Feb;28(1):87-95. doi: 10.1016/j.jcrc.2012.06.003. Epub 2012 Aug 27.

PMID:
22951019
[PubMed - indexed for MEDLINE]
2.

Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions.

Cointault O, Kamar N, Bories P, Lavayssiere L, Angles O, Rostaing L, Genestal M, Durand D.

Nephrol Dial Transplant. 2004 Jan;19(1):171-8.

PMID:
14671053
[PubMed - indexed for MEDLINE]
Free Article
3.

Focusing on the basic principles of dialysis to optimize regional citrate anticoagulation.

Mariano F.

J Crit Care. 2013 Feb;28(1):99-100. doi: 10.1016/j.jcrc.2012.09.001. Epub 2012 Nov 14. No abstract available.

PMID:
23159145
[PubMed - indexed for MEDLINE]
4.

Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate.

Gupta M, Wadhwa NK, Bukovsky R.

Am J Kidney Dis. 2004 Jan;43(1):67-73.

PMID:
14712429
[PubMed - indexed for MEDLINE]
5.

Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience.

Morgera S, Scholle C, Voss G, Haase M, Vargas-Hein O, Krausch D, Melzer C, Rosseau S, Zuckermann-Becker H, Neumayer HH.

Nephron Clin Pract. 2004;97(4):c131-6.

PMID:
15331942
[PubMed - indexed for MEDLINE]
6.

Regional hemodialysis anticoagulation: hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A.

Flanigan MJ, Pillsbury L, Sadewasser G, Lim VS.

Am J Kidney Dis. 1996 Apr;27(4):519-24.

PMID:
8678062
[PubMed - indexed for MEDLINE]
7.

Quantification of systemic delivery of substrates for intermediate metabolism during citrate anticoagulation of continuous renal replacement therapy.

Balik M, Zakharchenko M, Otahal M, Hruby J, Polak F, Rusinova K, Stach Z, Vavrova J, Jabor A.

Blood Purif. 2012;33(1-3):80-7. doi: 10.1159/000334641. Epub 2011 Dec 30.

PMID:
22212643
[PubMed - indexed for MEDLINE]
8.

Regional citrate anticoagulation in continuous hemodialysis--acid-base and electrolyte balance at an increased dose of dialysis.

Morgera S, Haase M, Ruckert M, Krieg H, Kastrup M, Krausch D, Vargas-Hein O, Zuckermann-Becker H, Peters H, Pohlmeier R, Neumayer HH.

Nephron Clin Pract. 2005;101(4):c211-9. Epub 2005 Sep 8.

PMID:
16155399
[PubMed - indexed for MEDLINE]
9.

Magnesium flux during continuous venovenous haemodiafiltration with heparin and citrate anticoagulation.

Brain M, Anderson M, Parkes S, Fowler P.

Crit Care Resusc. 2012 Dec;14(4):274-82.

PMID:
23230876
[PubMed - indexed for MEDLINE]
10.

Citrate clearance in children receiving continuous venovenous renal replacement therapy.

Chadha V, Garg U, Warady BA, Alon US.

Pediatr Nephrol. 2002 Oct;17(10):819-24. Epub 2002 Sep 7.

PMID:
12376810
[PubMed - indexed for MEDLINE]
11.

Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needs.

Morabito S, Pistolesi V, Tritapepe L, Vitaliano E, Zeppilli L, Polistena F, Fiaccadori E, Pierucci A.

BMC Nephrol. 2013 Oct 25;14:232. doi: 10.1186/1471-2369-14-232.

PMID:
24156306
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Regional citrate anticoagulation for hemodialysis: calcium-free vs. calcium containing dialysate - a randomized trial.

Buturovic-Ponikvar J, Cerne S, Gubensek J, Ponikvar R.

Int J Artif Organs. 2008 May;31(5):418-24.

PMID:
18609515
[PubMed - indexed for MEDLINE]
13.

The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury.

Durão MS, Monte JC, Batista MC, Oliveira M, Iizuka IJ, Santos BF, Pereira VG, Cendoroglo M, Santos OF.

Crit Care Med. 2008 Nov;36(11):3024-9. doi: 10.1097/CCM.0b013e31818b9100.

PMID:
18824904
[PubMed - indexed for MEDLINE]
14.

Effect of bicarbonate and lactate buffer on glucose and lactate metabolism during hemodiafiltration in patients with multiple organ failure.

Bollmann MD, Revelly JP, Tappy L, Berger MM, Schaller MD, Cayeux MC, Martinez A, Chioléro RL.

Intensive Care Med. 2004 Jun;30(6):1103-10. Epub 2004 Mar 27.

PMID:
15048552
[PubMed - indexed for MEDLINE]
15.

Continuous veno-venous haemodialysis with a novel bicarbonate dialysis solution: prospective cross-over comparison with a lactate buffered solution.

Zimmerman D, Cotman P, Ting R, Karanicolas S, Tobe SW.

Nephrol Dial Transplant. 1999 Oct;14(10):2387-91.

PMID:
10528662
[PubMed - indexed for MEDLINE]
Free Article
16.

A simple, safe and effective citrate anticoagulation protocol for the genius dialysis system in acute renal failure.

Morgera S, Scholle C, Melzer C, Slowinski T, Liefeld L, Baumann G, Peters H, Neumayer HH.

Nephron Clin Pract. 2004;98(1):c35-40.

PMID:
15361702
[PubMed - indexed for MEDLINE]
17.

Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation.

Swartz R, Pasko D, O'Toole J, Starmann B.

Clin Nephrol. 2004 Feb;61(2):134-43.

PMID:
14989634
[PubMed - indexed for MEDLINE]
18.

An amino acid-based peritoneal dialysis fluid buffered with bicarbonate versus glucose/bicarbonate and glucose/lactate solutions: an intraindividual randomized study.

Plum J, Erren C, Fieseler C, Kirchgessner J, Passlick-Deetjen J, Grabensee B.

Perit Dial Int. 1999 Sep-Oct;19(5):418-28.

PMID:
11379854
[PubMed - indexed for MEDLINE]
Free Article
19.

Citrate anticoagulation during post-dilution hemodiafiltration with a high cut-off (Theralite) membrane.

Kovač J, Gubenšek J, Pernat AM, Buturović-Ponikvar J, Kersnič B, Pretnar J, Ponikvar R.

Ther Apher Dial. 2011 Jun;15(3):283-6. doi: 10.1111/j.1744-9987.2011.00952.x.

PMID:
21624077
[PubMed - indexed for MEDLINE]
20.

Effect of regional citrate anticoagulation on thrombogenicity and biocompatibility during CVVHDF.

Polanská K, Opatrný K Jr, Rokyta R Jr, Krouzecký A, Vit L, Kasal E.

Ren Fail. 2006;28(2):107-18.

PMID:
16538967
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk